201 related articles for article (PubMed ID: 22878175)
1. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
Dahlmann M; Sack U; Herrmann P; Lemm M; Fichtner I; Schlag PM; Stein U
Oncotarget; 2012 Aug; 3(8):783-97. PubMed ID: 22878175
[TBL] [Abstract][Full Text] [Related]
2. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.
Huang L; Xu Y; Cai G; Guan Z; Cai S
Oncol Rep; 2012 Apr; 27(4):917-22. PubMed ID: 22200787
[TBL] [Abstract][Full Text] [Related]
4. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
5. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
7. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
Shi Y; Zou M; Collison K; Baitei EY; Al-Makhalafi Z; Farid NR; Al-Mohanna FA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
[TBL] [Abstract][Full Text] [Related]
8. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
[TBL] [Abstract][Full Text] [Related]
9. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
10. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
11. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
12. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
[TBL] [Abstract][Full Text] [Related]
13. RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.
Liu J; Fu S; Xu Y; Zheng Z
Mol Med Rep; 2014 Sep; 10(3):1389-94. PubMed ID: 24969174
[TBL] [Abstract][Full Text] [Related]
14. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
[TBL] [Abstract][Full Text] [Related]
15. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
17. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo.
Hua J; Chen D; Fu H; Zhang R; Shen W; Liu S; Sun K; Sun X
Cancer Lett; 2010 Jun; 292(1):41-7. PubMed ID: 19945782
[TBL] [Abstract][Full Text] [Related]
18. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.
Ma X; Yang Y; Wang Y; An G; Lv G
Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization.
Fabris L; Cadamuro M; Moserle L; Dziura J; Cong X; Sambado L; Nardo G; Sonzogni A; Colledan M; Furlanetto A; Bassi N; Massani M; Cillo U; Mescoli C; Indraccolo S; Rugge M; Okolicsanyi L; Strazzabosco M
Hepatology; 2011 Sep; 54(3):890-9. PubMed ID: 21618579
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
Zhang K; Yu M; Hao F; Dong A; Chen D
Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
